A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

Clinical trial NCT05113771 · COMPLETED

Trial details

NCT number: NCT05113771
Sponsor: Denovo Biopharma LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Resistant Depression

Start date: 2022-06-29
Primary completion: 2024-02-06
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.